This study is a phase 2/3 open-label controlled trial (CT) in which adults with Major Depressive Disorder (MDD) and adults who have MDD plus comorbid Inflammatory Bowel Syndrome (IBS) will be assigned to either receive oral Fecal Microbiota Transplantation (FMT) or to continue wi…
Phase: PHASE2, PHASE3 • Sponsor: Valerie Taylor
Last updated Mar 30, 2026 14:29 UTC